Free Trial

Iradimed (IRMD) Earnings Date, Estimates & Call Transcripts

$42.19
-0.95 (-2.20%)
(As of 05/29/2024 ET)

Earnings Summary

Upcoming
Earnings Date
Aug. 1Estimated
Actual EPS
(May. 2)
$0.32 Beat By $0.01
Consensus EPS
(May. 2)
$0.31
Skip Charts & View Estimated and Actual Earnings Data

IRMD Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

IRMD Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Iradimed Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20241$0.31$0.31$0.310.330 - 0.350
Q2 20241$0.35$0.35$0.350.360 - 0.390
Q3 20241$0.34$0.34$0.34 
Q4 20241$0.39$0.39$0.39 
FY 20244$1.39$1.39 $1.39

IRMD Earnings Date and Information

Iradimed last posted its quarterly earnings data on May 2nd, 2024. The medical equipment provider reported $0.32 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.31 by $0.01. The firm earned $17.60 million during the quarter, compared to the consensus estimate of $17.26 million. Iradimed has generated $1.41 earnings per share over the last year ($1.41 diluted earnings per share) and currently has a price-to-earnings ratio of 29.9. Earnings for Iradimed are expected to grow by 21.28% in the coming year, from $1.41 to $1.71 per share. Iradimed has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 1st, 2024 based off prior year's report dates.

Iradimed Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
8/1/2024
(Estimated)
------- 
5/2/2024Q1 2024$0.31$0.32+$0.01$0.32$17.26 million$17.60 million
2/8/2024Q4 2023$0.37$0.36($0.01)$0.36-$17.45 million
11/3/2023Q3 2023$0.34$0.40+$0.06$0.40$16.21 million$16.51 million
8/3/2023Q2 2023$0.28$0.33+$0.05$0.33$15.70 million$16.13 million
5/4/2023Q1 2023$0.25$0.27+$0.02$0.27$14.76 million$15.48 million    
2/2/2023Q4 2022$0.29$0.29-$0.29$14.93 million$14.86 million
11/3/2022Q3 2022$0.23$0.27+$0.04$0.27$13.17 million$13.41 million
7/29/2022Q2 2022$0.20$0.26+$0.06$0.26$12.64 million$12.72 million
4/29/2022Q1 2022$0.18$0.20+$0.02$0.20$12.21 million$12.31 million    
2/3/2022Q4 2021$0.21$0.33+$0.12$0.31$11.66 million$11.87 million    
10/28/2021Q3 2021$0.17$0.23+$0.06$0.20$10.39 million$10.91 million    
7/29/2021Q2 2021$0.10$0.14+$0.04$0.12$9.58 million$9.81 million  
4/29/2021Q1 2021$0.10$0.13+$0.03$0.11$8.36 million$9.22 million  
2/3/2021Q4 2020$0.11$0.07($0.04)$0.05$8.02 million$8.55 million  
11/4/2020Q3 2020$0.10$0.11+$0.01$0.09$7.46 million$7.70 million  
7/30/2020Q2 2020($0.07)$0.05+$0.12($0.17)$5.53 million$6.80 million  
4/30/2020Q1 2020$0.15$0.18+$0.03$0.14$8.72 million$8.68 million  
2/6/2020Q4 2019$0.20$0.30+$0.10$0.26$10.96 million$10.89 million  
10/30/2019Q3 2019$0.13$0.20+$0.07$0.20$9.85 million$9.96 million  
7/30/2019Q2 2019$0.12$0.17+$0.05$0.17$8.91 million$9.23 million

Iradimed Earnings - Frequently Asked Questions

When is Iradimed's earnings date?

Iradimed has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 1st, 2024 based off last year's report dates. Learn more on IRMD's earnings history.

Did Iradimed beat their earnings estimates last quarter?

In the previous quarter, Iradimed (NASDAQ:IRMD) reported $0.32 earnings per share (EPS) to beat the analysts' consensus estimate of $0.31 by $0.01. Learn more on analysts' earnings estimate vs. IRMD's actual earnings.

How much revenue does Iradimed generate each year?

Iradimed (NASDAQ:IRMD) has a recorded annual revenue of $65.56 million.

How much profit does Iradimed generate each year?

Iradimed (NASDAQ:IRMD) has a recorded net income of $17.19 million. IRMD has generated $1.41 earnings per share over the last four quarters.

What is Iradimed's price-to-earnings ratio?

Iradimed (NASDAQ:IRMD) has a trailing price-to-earnings ratio of 29.92 and a forward price-to-earnings ratio of 29.92.

What is Iradimed's EPS forecast for next year?

Iradimed's earnings are expected to grow from $1.41 per share to $1.71 per share in the next year, which is a 21.28% increase.


More Earnings Resources from MarketBeat

This page (NASDAQ:IRMD) was last updated on 5/30/2024 by MarketBeat.com Staff

From Our Partners